title: Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial.
abstract: BACKGROUND
  Non-steroidal anti-inflammatory drugs (NSAIDs) are used routinely to control pain and inflammation after surgery in dogs. Robenacoxib is a new NSAID with high selectivity for the cyclo-oxygenase (COX)-2 isoform of COX. The objective of this study was to evaluate the efficacy and tolerability of robenacoxib for the management of peri-operative pain and inflammation associated with soft tissue surgery in dogs. The study was a prospective, randomized, blinded, positive-controlled, non-inferiority, multi-center clinical trial. A total of 174 dogs undergoing major soft tissue surgery were included and randomly allocated in a 2:1 ratio to receive either robenacoxib (n = 118) or the positive control, meloxicam (n = 56). Each dog received an initial dose subcutaneously prior to surgery (robenacoxib 2 mg/kg, meloxicam 0.2 mg/kg), followed by daily oral doses (robenacoxib 1-2 mg/kg, meloxicam 0.1 mg/kg) for 12 days (range 10-14) after surgery. Pain and inflammation were assessed subjectively using the Glasgow Composite Pain Scale (GCPS) by clinicians as the primary end point and additional evaluations by the clinicians and animal owners as secondary endpoints.
  
  
  RESULTS
  Both treatments provided similar pain control, with no significant differences between groups for any efficacy variable using non-parametric analyses (Mann-Whitney U test). In no dog was analgesic rescue therapy administered. Non-inferior efficacy of robenacoxib compared to meloxicam was demonstrated statistically for the primary and all secondary endpoints using parametric analysis of variance, although the data were not normally distributed even after log transformation. For the primary endpoint (reciprocal of the modified GCPS score), the relative efficacy of robenacoxib/meloxicam was 1.12 with a 95% confidence interval of 0.97-1.29.
  
  
  CONCLUSIONS
  A treatment regimen of robenacoxib by subcutaneous injection followed by oral tablets had good tolerability and non-inferior efficacy compared to meloxicam for the management of peri-operative pain and inflammation associated with soft tissue surgery in dogs.
authors: Philippe
authors: P
authors: Gruet
authors: Wolfgang
authors: W
authors: Seewald
authors: Jonathan N
authors: JN
authors: King
mesh_terms: D000818:Animals; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004159:Diphenylamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D004285:Dogs / Q000601:surgery*; D004311:Double-Blind Method; D005260:Female; D006854:Hydrocortisone / Q000097:blood; D007249:Inflammation / Q000188:drug therapy / Q000662:veterinary*; D008297:Male; D000077239:Meloxicam; D010146:Pain / Q000188:drug therapy / Q000662:veterinary*; D010147:Pain Measurement / Q000662:veterinary; D010648:Phenylacetates / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D011446:Prospective Studies; D018709:Statistics, Nonparametric; D013843:Thiazines / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D013844:Thiazoles / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D010648:Phenylacetates; D013843:Thiazines; D013844:Thiazoles; D004159:Diphenylamine; D000077239:Meloxicam; D006854:Hydrocortisone; C551524:robenacoxib
references: J Vet Med Sci. 2007 Sep;69(9):939-44
references: 17917379
references: Rheumatology (Oxford). 2007 Jun;46(6):911-9
references: 17459958
references: J Vet Med Sci. 2012 Oct;74(10):1283-9
references: 22673062
references: Vet Anaesth Analg. 2006 Jul;33(4):246-57
references: 16764590
references: Vet Anaesth Analg. 2013 May;40(3):297-307
references: 23279623
references: J Vet Pharmacol Ther. 2011 Jun;34(3):298-311
references: 21492194
references: Am J Vet Res. 2011 Feb;72(2):184-93
references: 21281192
references: Am J Vet Res. 2001 Jun;62(6):882-8
references: 11400845
references: Vet Rec. 2008 Mar 29;162(13):403-8
references: 18375984
references: Res Vet Sci. 2010 Jun;88(3):497-506
references: 20004922
references: Vet Anaesth Analg. 2005 Jul;32(4):184-92
references: 16008715
references: Can Vet J. 2003 Jul;44(7):565-70
references: 12892286
references: J Vet Pharmacol Ther. 2009 Feb;32(1):41-8
references: 19161454
references: Vet Anaesth Analg. 2007 May;34(3):200-8
references: 17444933
references: Vet Surg. 2012 Apr;41(3):336-44
references: 22225463
references: J Am Vet Med Assoc. 2006 Oct 1;229(7):1103-12
references: 17014357
references: J Vet Pharmacol Ther. 2009 Feb;32(1):1-17
references: 19161451
references: Am J Vet Res. 2007 Mar;68(3):258-64
references: 17331014
references: J Vet Pharmacol Ther. 2010 Apr;33(2):118-31
references: 20444036
references: Vet Rec. 2001 Apr 28;148(17):525-31
references: 11354645
references: Am J Vet Res. 1997 Jun;58(6):626-31
references: 9185970
references: Am J Vet Res. 2005 Dec;66(12):2154-66
references: 16379662
references: J Am Anim Hosp Assoc. 2007 Sep-Oct;43(5):235-48
references: 17823472
references: Vet J. 2005 Jul;170(1):138-40
references: 15993799
references: J Am Vet Med Assoc. 2013 Mar 1;242(5):631-42
references: 23402410
references: JAMA. 2006 Mar 8;295(10):1152-60
references: 16522836